These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33538811)

  • 1. The 49th Annual Meeting of the Japanese Society for Immunology: COVID-19 and Immunity.
    Shinkura R; Kang S; Arase H; Toyama-Sorimachi N
    Int Immunol; 2021 Mar; 33(4):193-196. PubMed ID: 33538811
    [No Abstract]   [Full Text] [Related]  

  • 2. Covid-19 vaccines: delivering protective immunity.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Dec; 371():m4838. PubMed ID: 33334862
    [No Abstract]   [Full Text] [Related]  

  • 3. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 4. Covid-19 vaccination: evidence of waning immunity is overstated.
    Scott J; Richterman A; Cevik M
    BMJ; 2021 Sep; 374():n2320. PubMed ID: 34556464
    [No Abstract]   [Full Text] [Related]  

  • 5. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
    Priyanka ; Choudhary OP; Singh I
    Travel Med Infect Dis; 2021; 39():101911. PubMed ID: 33186686
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
    de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
    Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
    Alikhani M; Javadi A; Aalikhani M
    Iran J Immunol; 2021 Mar; 18(1):93-94. PubMed ID: 33787518
    [No Abstract]   [Full Text] [Related]  

  • 9. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 10. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo.
    Escobedo RA; Singh DK; Kaushal D
    Front Immunol; 2021; 12():765349. PubMed ID: 34858417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
    Tan LY; Komarasamy TV; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():742941. PubMed ID: 34659238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for SARS coronavirus 2 and the new normal in vaccinology.
    Griffiths PD
    Rev Med Virol; 2021 Mar; 31(2):e2229. PubMed ID: 33666285
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity to glycan α-Gal and possibilities for the control of COVID-19.
    la Fuente J; Gortázar C; Cabezas-Cruz A
    Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805
    [No Abstract]   [Full Text] [Related]  

  • 16. A new generation of vaccines based on alphavirus self-amplifying RNA.
    Ballesteros-Briones MC; Silva-Pilipich N; Herrador-Cañete G; Vanrell L; Smerdou C
    Curr Opin Virol; 2020 Oct; 44():145-153. PubMed ID: 32898764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
    Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
    Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.